Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Anaptysbio (ANAB) Other Non Operating Income (2016 - 2025)

Anaptysbio filings provide 10 years of Other Non Operating Income readings, the most recent being -$3000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income fell 114.29% year-over-year to -$3000.0, compared with a TTM value of $5.4 million through Dec 2025, up 38685.71%, and an annual FY2025 reading of $5.4 million, up 38685.71% over the prior year.
  • Other Non Operating Income hit -$3000.0 in Q4 2025 for Anaptysbio, down from $3.5 million in the prior quarter.
  • The five-year high for Other Non Operating Income was $3.5 million in Q2 2025, with the low at -$5000.0 in Q3 2024.
  • Median Other Non Operating Income over the past 5 years was $3000.0 (2021), compared with a mean of $323000.0.
  • The sharpest move saw Other Non Operating Income crashed 600.0% in 2024, then skyrocketed 95200.0% in 2025.
  • Year by year, Other Non Operating Income stood at $1000.0 in 2021, then plummeted by 500.0% to -$4000.0 in 2022, then skyrocketed by 50.0% to -$2000.0 in 2023, then soared by 1150.0% to $21000.0 in 2024, then tumbled by 114.29% to -$3000.0 in 2025.
  • According to Business Quant data, Other Non Operating Income over the past three periods came in at -$3000.0, $3.5 million, and $1.9 million for Q4 2025, Q2 2025, and Q1 2025 respectively.